Carotid Artery Disease
What's New
Last Posted: Jul 27, 2024
- Genetic Polymorphisms in Cardiovascular Disease: Effects Across Three Generations Exposed to Radiation from the Semipalatinsk Nuclear Test Site.
Geir Bjørklund, et al. Cardiovascular toxicology 2024 0 - SERPINE1 and MTHFR genetic variants in patients with embolic stroke of undetermined source: links with fibrin clot properties.
Adrianna Klajmon, et al. Neurologia i neurochirurgia polska 2024 0 - Total serum homocysteine--a predictor of extracranial carotid artery stenosis in male patients with symptomatic peripheral arterial disease.
Mueller T, et al. Vascular medicine (London, England) 2002 0 (3) 163-7 - Association between the rs2279238 of the Liver X receptor alpha gene polymorphism and advanced carotid atherosclerosis in the Slovenian cohort.
Grbi? Emin, et al. Gene 2022 10 146764 - A Systematic Review and Bibliometric Analysis of Applications of Artificial Intelligence and Machine Learning in Vascular Surgery.
Javidan Arshia P et al. Annals of vascular surgery 2022 - Genome Wide Epistasis Study of On-Statin Cardiovascular Events with Iterative Feature Reduction and Selection.
Adams Solomon M et al. Journal of personalized medicine 2020 Nov 10(4) - Association between rs2107595 HDAC9 gene polymorphism and advanced carotid atherosclerosis in the Slovenian cohort.
Grbi? Emin, et al. Lipids in health and disease 2020 4 (1) 71 - Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.
Blazer Ashira, et al. PloS one 2017 0 (8) e0182483 - PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity.
Kim Daniel Seung, et al. Journal of lipid research 2015 7 (7) 1351-62 - Role of rs1466535 low density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism in carotid artery disease.
Giusti Betti, et al. Atherosclerosis 2014 11 (1) 135-7 - Atherosclerosis
From NHLBI health topic site - Carotid Artery Disease
From NHLBI health topic site - Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease.
Kim Daniel S, et al. Journal of lipids 2012 0 476316 - Association of OX40L polymorphisms with sporadic breast cancer in northeast Chinese Han population.
Weiguang Yuan, et al. PloS one 2012 0 (8) e41277 - Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk.
Ronald James, et al. Stroke; a journal of cerebral circulation 2011 1 (1) 2-9 - Genetic and nongenetic sources of variation in phospholipid transfer protein activity.
Jarvik Gail P, et al. Journal of lipid research 2010 5 (5) 983-90 - Methylentetrahydrofolate reductase and nitric oxide synthase polymorphism in patients with atherosclerosis and diabetes.
Szabó Gábor Viktor, et al. Pathology oncology research : POR 2009 12 (4) 631-7 - Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q.
Ober Carole, et al. Journal of lipid research 2009 5 (5) 798-806 - Genetic variants of TNFSF4 and risk for carotid artery disease and stroke.
Olofsson P S, et al. Journal of molecular medicine (Berlin, Germany) 2009 4 (4) 337-46 - A novel Zip2 Gln/Arg/Leu codon 2 polymorphism is associated with carotid artery disease in aging.
Giacconi Robertina, et al. Rejuvenation research 2008 4 (2) 297-300 - A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk.
Crawford Dana C, et al. Journal of lipid research 2008 3 (3) 588-96 - What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia?
Altamura C, et al. European journal of neurology : the official journal of the European Federation of Neurological Societies 2007 6 (6) 679-82 - Apolipoprotein E polymorphism and preclinical carotid artery disease in untreated hypertensive men.
Bleil Maria E, et al. European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2006 2 (1) 98-100 - TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects.
Carlson Christopher S, et al. Human genetics 2007 3 (1) 65-75 - Association of the -159C/T polymorphism of the endotoxin receptor (CD14) with carotid artery disease and cardiovascular mortality in dialysis patients.
Losito Attilio, et al. Blood purification 2005 0 (2) 128-33 - The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status.
Rozek Laura S, et al. Journal of lipid research 2005 9 (9) 1888-95 - Marburg I polymorphism of factor VII--activating protease: a prominent risk predictor of carotid stenosis.
Willeit Johann, et al. Circulation 2003 2 (5) 667-70 - Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype.
Jarvik G P, et al. Arteriosclerosis, thrombosis, and vascular biology 2000 11 (11) 2441-7
About HLBS-PopOmics
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
Content Summary
Common HLBS Health Categories
Site Citation:
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: